Ray Elliott Retiring: Is Boston Scientific On Or Off Track?
This article was originally published in The Gray Sheet
Executive Summary
Ray Elliott's surprise retirement announcement from Boston Scientific last week was to some a warning sign that the company's challenges are even bigger than expected, but the CEO argues it is just the opposite. He says he has accomplished what he came to do.
You may also be interested in...
Boston Scientific Gains J&J Device Chief As President, Then CEO
Boston Scientific will have three successive CEOs over the next 14 months in a transition process that will end with the current device and diagnostics business chief for long-time rival Johnson & Johnson taking the helm.
Boston Scientific Gains J&J Device Chief As President, Then CEO
Boston Scientific will have three successive CEOs over the next 14 months in a transition process that will end with the current device and diagnostics business chief for long-time rival Johnson & Johnson taking the helm.
Medtronic Mines GE For New Chief; Omar Ishrak Starts In June
Medtronic's incoming CEO has run a similarly sized medical technology business in terms of sales for the past two years, albeit with a focus on diagnostic and monitoring tools rather than therapeutic technologies.